Nevertheless, our findings propose S100B-RAGE axis as a relevant contributor to the pathogenesis of the disease, and its blockade may be suggested as a rational target for therapeutic intervention in ALS. The gene discussed is S100B; the disease is amyotrophic lateral sclerosis.